Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Huaren Pharmaceutical Co., Ltd. (300110.SZ)

Compare
2.9700
0.0000
(0.00%)
At close: April 18 at 3:04:04 PM GMT+8
Loading Chart for 300110.SZ
  • Previous Close 2.9700
  • Open 3.0300
  • Bid 2.9700 x --
  • Ask 2.9800 x --
  • Day's Range 2.9500 - 3.0200
  • 52 Week Range 2.7100 - 4.3200
  • Volume 12,187,800
  • Avg. Volume 19,323,811
  • Market Cap (intraday) 3.511B
  • Beta (5Y Monthly) 0.31
  • PE Ratio (TTM) 24.75
  • EPS (TTM) 0.1200
  • Earnings Date --
  • Forward Dividend & Yield 0.02 (0.71%)
  • Ex-Dividend Date Jul 10, 2024
  • 1y Target Est --

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and sugar metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, it offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. The company was founded in 1998 and is based in Qingdao, China.

www.qdhuaren.com

2,681

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300110.SZ

View More

Performance Overview: 300110.SZ

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300110.SZ
15.62%
SSE Composite Index (000001.SS)
2.24%

1-Year Return

300110.SZ
10.20%
SSE Composite Index (000001.SS)
6.59%

3-Year Return

300110.SZ
25.96%
SSE Composite Index (000001.SS)
2.54%

5-Year Return

300110.SZ
30.63%
SSE Composite Index (000001.SS)
15.44%

Compare To: 300110.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300110.SZ

View More

Valuation Measures

Annual
As of 4/18/2025
  • Market Cap

    3.51B

  • Enterprise Value

    4.98B

  • Trailing P/E

    23.99

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.35

  • Price/Book (mrq)

    1.27

  • Enterprise Value/Revenue

    3.34

  • Enterprise Value/EBITDA

    20.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.81%

  • Return on Assets (ttm)

    3.80%

  • Return on Equity (ttm)

    5.52%

  • Revenue (ttm)

    1.49B

  • Net Income Avi to Common (ttm)

    146.51M

  • Diluted EPS (ttm)

    0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    120.1M

  • Total Debt/Equity (mrq)

    56.09%

  • Levered Free Cash Flow (ttm)

    -238.62M

Research Analysis: 300110.SZ

View More

Company Insights: 300110.SZ

Research Reports: 300110.SZ

View More

People Also Watch